INS and diabetes mellitus: Despite advancements in available insulin (e.g., faster- and longer-acting) and diabetes technology (e.g., continuous glucose monitors (CGMs), insulin pumps, automated delivery systems), ethnically and racially diverse adolescents with low income often do not have access to these innovations, impeding their ability to obtain or maintain optimal glycemic levels [3,4].